A program to support older cancer patients through social networks
Official title: A Single Arm Pilot Trial of a Social Network Intervention (SONATA) for Older Patients With Cancer
Run by University of Rochester · NCT05745038 · Data updated 2026-11-12
This study is testing a new support program that helps older cancer patients connect with others during their treatment to see if they find it helpful and if they stick with it.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 60 Years and up |
| Sex | All |
| Enrollment | 330 (estimated) |
| Sponsor | University of Rochester Academic / other |
| Locations | 1 site (Rochester, New York) |
| Status | Recruiting |
| Started | November 29, 2023 |
| Main results expected | December 31, 2027 |
| Study ends | June 30, 2028 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT05745038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 60 and older with a diagnosis of advanced or likely incurable cancer who can communicate in English.
✕Probably not a fit
Patients with psychiatric or cognitive impairments that interfere with participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the feasibility and acceptability of the SONATA program, a social network support intervention designed for older individuals undergoing treatment for advanced cancer. The program consists of six coaching sessions over approximately four months, with the first five sessions occurring every one to two weeks and the final session held one to two months later. The study aims to determine if at least 70% of enrolled patients complete three sessions and if the average acceptability score meets or exceeds four on a five-point scale.
Why it matters
Potential benefit: If successful, this program could enhance the support and adherence to treatment for older cancer patients, potentially improving their overall outcomes.
How similar studies have gone: While this approach is relatively novel, similar interventions in geriatric oncology have shown promise in enhancing patient support and adherence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient Inclusion Criteria: 1. Age ≥60 years 2. A diagnosis of advanced or likely incurable cancer, as determined by the primary oncologist 3. Able to speak English 4. Able to provide informed consent Exclusion Criteria: 1\) Any psychiatric or cognitive impairments interfering with participation as determined by the primary oncology team Network Members: Inclusion Criteria: 1. Age ≥18 years 2. Identified as a network member by patient subjects (up to 10 network members) 3. Able to speak English 4. Able to provide informed consent. Exclusion Criteria: None
Where it's running
-
University of Rochester
Rochester, New York, United States Recruiting
Study contacts
- Principal investigator: Kah Poh Loh — University of Rochester
- Study coordinator: Kah Poh Loh
- Email: Kahpoh_Loh@URMC.Rochester.edu
- Phone: 585-276-4353
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-photon microscopy on skin biopsies to help diagnose skin lesions
This study tests whether images from two-photon fluorescence microscopy of dermatology biopsies can match the diagnosis determined by standard histology.
-
Machine learning assessment of two-photon microscopy images from skin biopsies
A machine learning model is tested on two-photon microscopy images of skin biopsy samples taken in clinic to see if it can correctly predict basal cell carcinoma, squamous cell carcinoma, or non-cancer compared with standard histology.
-
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
This study checks whether brain health and well‑being differ for people with leukemia who are starting or on TKI therapy compared with similar individuals without cancer or TKI exposure.
-
Personalized cardiac imaging approach for women with early breast cancer on HER2 therapy
This study tests a personalized, risk-based plan to reduce unnecessary heart imaging while still catching heart problems early in women with HER2-positive breast cancer receiving HER2-targeted therapy.
-
Remote Assessments and Genetic Factors in Congenital and Childhood DM1
This study tests how congenital, childhood, and juvenile DM1 affect kids by doing remote visits, activities, and a small blood sample to explore symptoms and genetics.
-
Observing Healthy Lung Function with MRI and Breathing Tests
A study will test whether airway resistance measured by an oscillometer matches ventilation defects seen on PREFUL MRI in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.